Research Article

The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism

Table 2

Test characteristics of ARR to screen for PA according to stratified GFR.

eGFROptimal cut-offSensitivity (95% CI)Specificity (95% CI)Positive LR (95% CI)Negative LR (95% CI)

ALL18100.0 (95.4–100.0)71.38 (67.6–75.0)3.5 (3.1–4.0)
4092.4 (84.2–97.2)90.3 (87.7–92.6)9.6 (7.4–12.3)0.1 (0.0-0.1)
5282.3 (72.1–90.0)94.7 (92.6–97.3)15.5 (10.9–22.0)0.2 (0.1–0.3)
<9018100.0 (87.2–100.0)95.3 (92.0–97.6)21.3 (12.3–37.1)
4085.2 (66.3–95.8)100.0 (98.6–100.0)0.2 (0.1–0.4)
5285.2 (66.3–95.8)100.0 (98.6–100.0)0.2 (0.1–0.4)
≥9018100.0 (93.2–100.0)90.7 (87.2–93.6)10.8 (7.8–15.0)
40100.0 (93.2–100.0)90.7 (87.2–93.6)10.8 (7.8–15.0)
5298.1 (89.7–100.0)95.4 (92.6–97.3)21.2 (13.1–34.2)0.0 (0.0-0.1)

ARR, aldosterone-to-renin ratio; eGFR, estimated glomerular filtration rate; PA, primary aldosteronism; LR, likelihood ratios; CI, confidence interval.